RENO, Nev., Jan. 11 /PRNewswire/ -- The Woodrow Wilson International Center for Scholars today released a policy analysis of an industry that is projected to top $1-trillion within a decade -- nanotechnology. The report outlines a "menu of possibilities" for government action to deal with the "adverse" effects of nanotechnology, and provides evidence that the author says is relevant to determining what needs to be done to manage the industry. As an independent creator and leading supplier of advanced ceramic nanomaterials, Altair Nanotechnologies CEO Alan Gotcher can share his thoughts on how this could include a facts based approach. WHO: Alan J. Gotcher, Ph.D. President and chief executive officer of Altair Nanotechnologies http://www.altairnano.com WHY: Regulation of nanoparticles needs to be fact driven. In order to get the facts, we need to stimulate both increased federal investment in research and development to better understand the various families/classes of nanomaterials, and the development of strong corporate commitment to good nanotechnology stewardship. Altair Nanotechnologies is already on the road to strong corporate stewardship, with an ongoing partnership to study environmental and occupational safety with the National Institute for Occupational Safety and Health. HOW: Contact Sanda Pecina (202-367-1622, firstname.lastname@example.org) or Matt Taylor (202-367-1626) to schedule an interview or background briefing. ABOUT ALTAIR NANOTECHNOLOGIES INC. Altairnano is a leading supplier and innovator of advanced ceramic nanomaterial technology. Based in Reno, Nevada, Altairnano has assembled a unique team of materials scientists who, coupled in collaborative ventures with industry partners and leading academic centers, have pioneered an array of intellectual property and products. Altairnano's robust proprietary technology platforms produce a variety of crystalline and non-crystalline nanomaterials of unique structure, performance, quality and cost. The company has scalable manufacturing capability to meet emerging nanomaterials demands. Altairnano's two divisions, Life Sciences and Performance Materials, are focused on applications where its nanotechnology may enable new high growth markets. The Life Sciences division is pursuing market applications in pharmaceuticals, drug delivery, dental materials and other medical markets. The Performance Materials division is focused on market applications in advanced materials for paints and coatings; air and water treatment and alternative energy, including new lithium ion battery electrode materials. For additional information on Altairnano and its nanomaterials, visit http://www.altairnano.com.
SOURCE Altair Nanotechnologies Inc.